Alcidion Group Limited (ALC.AX) Stock Analysis & Winston Score

Alcidion Group is an Australian healthcare technology company that builds software for hospitals and health systems. Its main product is Miya, a platform that helps doctors and nurses manage patient information, track deteriorating patients, and coordinate care across a hospital. Its customers are mostly public hospitals in Australia, New Zealand, and the United Kingdom. Alcidion makes money by selling software licenses and long-term subscription contracts to hospital networks, which creates recurring revenue. The company operates primarily across Australia and has been expanding in the UK's National Health Service, which represents a significant growth opportunity. With a market cap of around $100 million, it is a small player in a fragmented market, competing against much larger global vendors like Epic and Oracle Health. The main risk is that long NHS procurement cycles and budget pressures can slow contract wins and delay revenue growth.